Morgan Stanley Tonix Pharmaceuticals Holding Corp. Transaction History

Morgan Stanley

  • $1.27 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.46 - $1.3 $228,651 - $646,188
497,068 Added 231.3%
711,969 $420,000
Q4 2022

Feb 14, 2023
SELL
$0.29 - $0.57 $208,414 - $409,642
-718,671 Reduced 76.98%
214,901 $83,000
Q3 2022

Nov 14, 2022
BUY
$0.53 - $1.9 $24,833 - $89,026
46,856 Added 5.28%
933,572 $498,000
Q2 2022

Aug 15, 2022
BUY
$1.58 - $7.36 $1.4 Million - $6.53 Million
886,716 New
886,716 $1.4 Million

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email